The Safetyof Dabigatran Versus Warfarin in Patients Undergoing Atrial Fibrillation Ablation

The safety and optimal strategy of the use of dabigatran versus uninterrupted warfarin in atrial fibrillation ablation is currently unclear. We performed a retrospective analysis between July 2011-October 2012 of all patients undergoing an AF ablation who received uninterrupted warfarin therapy (199...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Atr Fibrillation
Auteurs principaux: Garcia, Luis I, Mascarenhas, Mark A, Ahuja, Kartikya, Aizer, Anthony, Bernstein, Neil, Bernstein, Scott A, Fowler, Steve J, Holmes, Douglas S, Park, David S, Chinitz, Larry
Format: Artigo
Langue:Inglês
Publié: Cardiofront, Inc 2014
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4956124/
https://ncbi.nlm.nih.gov/pubmed/27957036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.965
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires